S. Philpott

发表

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.

I. Jacobs, U. Menon, M. Widschwendter, 2013, The Lancet. Oncology.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Matthew Burnell, Steven J Skates, Tim Mould, 2009, Journal of Family Planning and Reproductive Health Care.

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, A. Whittemore, 2015, Journal of the National Cancer Institute.

The Prevalence And Clinical Significance Of Mutations BRIP 1 , BARD 1 , PALB 2 And NBN Genes In Women With Ovarian Cancer

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, A. Whittemore, 2017 .

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers

I. Jacobs, U. Menon, M. Burnell, 2015, EBioMedicine.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Aarti Sharma, Naveena Singh, A. Mcguire, 2022, Journal of Medical Genetics.

Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.

A. Crook, H. Hemingway, A. Timmis, 2001, The New England journal of medicine.

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, B. Fridley, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

I. Jacobs, U. Menon, A. Ryan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study.

H. Hemingway, G. Feder, P. Boynton, 2001, Social Science & Medicine (1967).

Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer

A. Teschendorff, I. Jacobs, U. Menon, 2016, Oncotarget.

Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study

A. Crook, H. Hemingway, A. Timmis, 2001, Heart.

Evidence of stage-shift in women diagnosed with ovarian cancer during Phase 2 of the UK Familial Ovarian Cancer Screening Study (UKFOCSS)

I. Jacobs, U. Menon, A. Ryan, 2016 .

Society for Social Medicine annual meeting 2000

J. L. Budd, T. Peters, J. Pell, 2000, Journal of epidemiology and community health.

Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2).

I. Jacobs, U. Menon, S. Skates, 2013 .

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

B. Fridley, E. Goode, D. Bowtell, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

I. Jacobs, U. Menon, E. Benjamin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

"My tender heart and everything about me": women's accounts of health problems and symptoms prior to coronary angiography

H. Hemingway, P. Boynton, S. Philpott, 2000 .